Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 2.19 (+0.46%)
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 75.17 (+0.19%)
ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
DSNKY : 32.2000 (+4.34%)
GILD : 65.42 (+0.23%)
ARAY : 2.19 (+0.46%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 75.17 (+0.19%)
ONCY : 1.0900 (+0.93%)
ONC.TO : 1.47 (-1.34%)
DSNKY : 32.2000 (+4.34%)
GILD : 65.42 (+0.23%)
ARAY : 2.19 (+0.46%)
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 2.19 (+0.46%)
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy...

ARAY : 2.19 (+0.46%)
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenosâ„¢, for...

ARAY : 2.19 (+0.46%)
Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has opened the doors of its new global training facility, the Accuray...

ARAY : 2.19 (+0.46%)
Accuray to Host Investor Day at ASTRO on October 3, 2023

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3,...

ARAY : 2.19 (+0.46%)
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration...

ARAY : 2.19 (+0.46%)
Accuray: Fiscal Q4 Earnings Snapshot

Accuray: Fiscal Q4 Earnings Snapshot

ARAY : 2.19 (+0.46%)

Barchart Exclusives

Buy the Dip: This Top-Rated Cathie Wood Stock Has 39% Upside Potential
Discover why Wall Street analysts are largely bullish on DraftKings, with expectations of significant upside, in our latest deep dive on the stock's performance and future prospects. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar